GHRH + Secretagogue Blend
CJC-1295 (No DAC) + Ipamorelin
Pre-blended CJC-1295 and Ipamorelin formulated for laboratory study of endocrine signaling pathways.
5 in stock (can be backordered)
Product Details
CJC-1295 + Ipamorelin
-
Pre-blended GHRH analog (CJC-1295) and selective secretagogue (Ipamorelin)
Studied together for growth-hormone-axis research
-
CJC-1295 component investigated for sustained GHRH-receptor signaling
Extended half-life profile in research settings
-
Ipamorelin component referenced as a selective ghrelin-receptor agonist
Noted for minimal off-target activity in studies
Research Use Notes
-
Supplied as a co-lyophilized powder blend
Requires reconstitution before use
-
Research Water required for mixing (sold separately)
Mix gently and let dissolve fully
-
Transfer only once the solution is fully clear
Storage
-
Store sealed lyophilized vial frozen for long-term holding
-
Keep reconstituted blend at 2 to 8°C
Use within typical research handling window
Handling
-
Use sterile technique throughout reconstitution
For laboratory research use only
Handling and documentation
Supplied lyophilised. See our guide to reconstituting and storing lyophilised peptides for solvent selection and storage conditions.
Each batch is independently assayed. What those figures establish is covered in understanding peptide purity, and what a certificate of analysis actually verifies is explained separately.
Blended preparations are supplied where a protocol calls for more than one compound. An effect observed with a combination cannot be attributed to any single component without testing them separately — the individual compounds are listed under tissue repair research.